Heart disease risk assessment tools specific to women remain lacking, despite the fact cardiovascular disease is the leading cause of mortality in women.
4D Molecular Therapeutics’ gene therapy cuts Eylea use in wet AMD patients, biotech divulges plans for pivotal studies
4D Molecular Therapeutics said people with wet age-related macular degeneration (AMD) who received the company’s gene therapy as part of a clinical trial needed fewer